# Multi-disciplinary fairness considerations in machine learning for clinical trials

arXiv: https://arxiv.org/abs/2205.08875 · HTML: https://mlsanity.com/paper/2205.08875/

## Key facts

- Cited by 8 papers in the map (data through 14 Oct 2026).
- Builds on 50 of its 321 references that are in the map.
- First posted on arXiv 18 May 2022.

## Builds on (most cited first, 30 of 50)

- [Equality of Opportunity in Supervised Learning](https://mlsanity.com/paper/1610.02413/) (2016)
- [A Survey on Bias and Fairness in Machine Learning](https://mlsanity.com/paper/1908.09635/) (2019)
- [Counterfactual Fairness](https://mlsanity.com/paper/1703.06856/) (2017)
- [Certifying and removing disparate impact](https://mlsanity.com/paper/1412.3756/) (2014)
- [Fair prediction with disparate impact: A study of bias in recidivism prediction instruments](https://mlsanity.com/paper/1610.07524/) (2016)
- [Mitigating Unwanted Biases with Adversarial Learning](https://mlsanity.com/paper/1801.07593/) (2018)
- [Estimation and Inference of Heterogeneous Treatment Effects using Random Forests](https://mlsanity.com/paper/1510.04342/) (2015)
- [Inherent Trade-Offs in the Fair Determination of Risk Scores](https://mlsanity.com/paper/1609.05807/) (2016)
- [Fairness Beyond Disparate Treatment & Disparate Impact: Learning Classification without Disparate Mistreatment](https://mlsanity.com/paper/1610.08452/) (2016)
- [Learning Adversarially Fair and Transferable Representations](https://mlsanity.com/paper/1802.06309/) (2018)
- [Improving fairness in machine learning systems: What do industry practitioners need?](https://mlsanity.com/paper/1812.05239/) (2018)
- [Recursive Partitioning for Heterogeneous Causal Effects](https://mlsanity.com/paper/1504.01132/) (2015)
- [Time-uniform, nonparametric, nonasymptotic confidence sequences](https://mlsanity.com/paper/1810.08240/) (2018)
- [Multiaccuracy: Black-Box Post-Processing for Fairness in Classification](https://mlsanity.com/paper/1805.12317/) (2018)
- [Avoiding Discrimination through Causal Reasoning](https://mlsanity.com/paper/1706.02744/) (2017)
- [Fairness in Learning: Classic and Contextual Bandits](https://mlsanity.com/paper/1605.07139/) (2016)
- [Fairness in Machine Learning: Lessons from Political Philosophy](https://mlsanity.com/paper/1712.03586/) (2017)
- [Why Is My Classifier Discriminatory?](https://mlsanity.com/paper/1805.12002/) (2018)
- [The Frontiers of Fairness in Machine Learning](https://mlsanity.com/paper/1810.08810/) (2018)
- [Multi-armed Bandit Models for the Optimal Design of Clinical Trials: Benefits and Challenges](https://mlsanity.com/paper/1507.08025/) (2015)
- [Ethical Machine Learning in Health Care](https://mlsanity.com/paper/2009.10576/) (2020)
- [Human-Centered Tools for Coping with Imperfect Algorithms during Medical Decision-Making](https://mlsanity.com/paper/1902.02960/) (2019)
- [Safe Testing](https://mlsanity.com/paper/1906.07801/) (2019)
- [Fairness in Reinforcement Learning](https://mlsanity.com/paper/1611.03071/) (2016)
- [Confidence Intervals for Policy Evaluation in Adaptive Experiments](https://mlsanity.com/paper/1911.02768/) (2019)
- [Achieving Fairness in the Stochastic Multi-armed Bandit Problem](https://mlsanity.com/paper/1907.10516/) (2019)
- [Online Learning with an Unknown Fairness Metric](https://mlsanity.com/paper/1802.06936/) (2018)
- [From Parity to Preference-based Notions of Fairness in Classification](https://mlsanity.com/paper/1707.00010/) (2017)
- [Two Simple Ways to Learn Individual Fairness Metrics from Data](https://mlsanity.com/paper/2006.11439/) (2020)
- [Metric Learning for Individual Fairness](https://mlsanity.com/paper/1906.00250/) (2019)

## Built on by (most cited first, 8 of 8)

- [Causal machine learning for predicting treatment outcomes](https://mlsanity.com/paper/2410.08770/) (2024)
- [Open Challenges and Opportunities in Federated Foundation Models Towards Biomedical Healthcare](https://mlsanity.com/paper/2405.06784/) (2024)
- [TRIALSCOPE: A Unifying Causal Framework for Scaling Real-World Evidence Generation with Biomedical Language Models](https://mlsanity.com/paper/2311.01301/) (2023)
- [Fairness and Sequential Decision Making: Limits, Lessons, and Opportunities](https://mlsanity.com/paper/2301.05753/) (2023)
- [EARN Fairness: Explaining, Asking, Reviewing, and Negotiating Artificial Intelligence Fairness Metrics Among Stakeholders](https://mlsanity.com/paper/2407.11442/) (2024)
- [Clinical Trial Active Learning](https://mlsanity.com/paper/2307.11209/) (2023)
- [Critical Appraisal of Fairness Metrics in Clinical Predictive AI](https://mlsanity.com/paper/2506.17035/) (2025)
- [Artificial Intelligence-based Decision Support Systems for Precision and Digital Health](https://mlsanity.com/paper/2407.16062/) (2024)

## Abstract (arXiv)

While interest in the application of machine learning to improve healthcare has grown tremendously in recent years, a number of barriers prevent deployment in medical practice. A notable concern is the potential to exacerbate entrenched biases and existing health disparities in society. The area of fairness in machine learning seeks to address these issues of equity; however, appropriate approaches are context-dependent, necessitating domain-specific consideration. We focus on clinical trials, i.e., research studies conducted on humans to evaluate medical treatments. Clinical trials are a relatively under-explored application in machine learning for healthcare, in part due to complex ethical, legal, and regulatory requirements and high costs. Our aim is to provide a multi-disciplinary assessment of how fairness for machine learning fits into the context of clinical trials research and practice. We start by reviewing the current ethical considerations and guidelines for clinical trials and examine their relationship with common definitions of fairness in machine learning. We examine potential sources of unfairness in clinical trials, providing concrete examples, and discuss the role machine learning might play in either mitigating potential biases or exacerbating them when applied without care. Particular focus is given to adaptive clinical trials, which may employ machine learning. Finally, we highlight concepts that require further investigation and development, and emphasize new approaches to fairness that may be relevant to the design of clinical trials.
